William F. Regine

Radiation Oncology

Room GGK0101
Baltimore, MD 21201

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 82 publications

Adjuvant Chemotherapy ± Chemoradiotherapy for Adenocarcinoma of the Pancreatic Head: Results of the Radiotherapy Random Assignment of NRG Oncology/RTOG 0848.

Adjuvant Chemotherapy ± Chemoradiotherapy for Adenocarcinoma of the Pancreatic Head: Results of the Radiotherapy Random Assignment of NRG Oncology/RTOG 0848.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 15, 2026

Impact of a Precision Medicine Navigator on Genomic Test Utilization in Black Patients With Prostate Cancer.

Impact of a Precision Medicine Navigator on Genomic Test Utilization in Black Patients With Prostate Cancer.

Journal: JCO oncology practice

Published: March 03, 2026

High frequency of RB1 mutations p16 positive early stage oropharyngeal carcinoma: A genomic and transcriptomic analysis.

High frequency of RB1 mutations p16 positive early stage oropharyngeal carcinoma: A genomic and transcriptomic analysis.

Journal: Oral oncology

Published: December 17, 2025

Novel use of peak optimized particle therapy for the delivery of three-dimensional spatially fractionated radiotherapy.

Novel use of peak optimized particle therapy for the delivery of three-dimensional spatially fractionated radiotherapy.

Journal: Frontiers in oncology

Published: October 31, 2025

Bulky non-small cell lung cancer treated with two-field robust proton lattice boost followed by conventional chemoradiation.

Bulky non-small cell lung cancer treated with two-field robust proton lattice boost followed by conventional chemoradiation.

Journal: Clinical and translational radiation oncology

Published: February 17, 2025

Forward momentum: progressive change through diversity equity and inclusion initiatives in academic health care.

Forward momentum: progressive change through diversity equity and inclusion initiatives in academic health care.

Journal: JNCI cancer spectrum

Published: January 29, 2025

Results of an Integrated Phase I/II Prospective Clinical Trial (NEXIS) for Neoadjuvant Anti-PD-L1 (Durvalumab) and Anti-CTLA-4 (Tremelimumab) With Radiation for High-Risk Soft-Tissue Sarcoma of the Trunk and Extremities.

Results of an Integrated Phase I/II Prospective Clinical Trial (NEXIS) for Neoadjuvant Anti-PD-L1 (Durvalumab) and Anti-CTLA-4 (Tremelimumab) With Radiation for High-Risk Soft-Tissue Sarcoma of the Trunk and Extremities.

Journal: Cureus

Published: October 21, 2024

Proton therapy re-irradiation outcomes and genomic landscape of patients with recurrent head and neck cancer.

Proton therapy re-irradiation outcomes and genomic landscape of patients with recurrent head and neck cancer.

Journal: Oral oncology

Published: February 18, 2024

Cone-Beam CT Images as an Indicator of QACT During Adaptive Proton Therapy of Extremity Sarcomas.

Cone-Beam CT Images as an Indicator of QACT During Adaptive Proton Therapy of Extremity Sarcomas.

Journal: International journal of particle therapy

Published: October 24, 2023

Clinical Implementation and Dosimetric Evaluation of a Robust Proton Lattice Planning Strategy Using Primary and Robust Complementary Beams.

Clinical Implementation and Dosimetric Evaluation of a Robust Proton Lattice Planning Strategy Using Primary and Robust Complementary Beams.

Journal: International journal of radiation oncology, biology, physics

Published: October 23, 2023

A Longitudinal Metagenomic Comparative Analysis of Oral Microbiome Shifts in Patients Receiving Proton Radiation versus Photon Radiation for Head and Neck Cancer.

A Longitudinal Metagenomic Comparative Analysis of Oral Microbiome Shifts in Patients Receiving Proton Radiation versus Photon Radiation for Head and Neck Cancer.

Journal: Journal of cancer & allied specialties

Published: August 24, 2023

Post-treatment PET/CT for p16-positive oropharynx cancer treated with definitive proton therapy.

Post-treatment PET/CT for p16-positive oropharynx cancer treated with definitive proton therapy.

Journal: Journal of clinical imaging science

Published: July 19, 2023

Showing 1-12 of 82

Last Updated: 09/26/2026